EGFR and cancer: A cohort study by Peddireddy with 126 never smokers with NSCLC reported that activating EGFR mutations was significantly higher in females (67.6% Female vs. 26.7% Male; p = 0.002) after a multivariate logistic regression model controlling for sex, environmental smoke, age, and history of cancer (OR 5.13, 95% CI 1.47–18.0, p = 0.0105 for females) [37].